Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia:A systematic review and network meta-analysis of randomized controlled trials

导出原文传递学术成果认领

作者 Jing Xu ^[1] Kang Wu ^[2] Xiao Li ^[3] Chiah Shean Teo ^[4] Guangda Li ^[1] Yiming Pan ^[1] Li Hou ^[3] 学术成果认领

作者单位 First School of Clinical Medicine,Beijing University of Chinese Medicine,Beijing,100029,China;Department of Oncology and Hematology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing,100700,China ^[1] First School of Clinical Medicine,Beijing University of Chinese Medicine,Beijing,100029,China ^[2] Department of Oncology and Hematology,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing,100700,China ^[3] Institut Kanser Negara,Ministry of Health Malaysia,Putrajaya,62250,Malaysia ^[4]

关键词 Cancer-related anemia Chinese patent medicine Network meta-analysis Effectiveness Safety

栏目名称 Original Articles

发布时间 2023-05-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览16
被引0
下载0

中医科学杂志（英文）

2023年10卷2期

150-160页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia:A systematic review and network meta-analysis of randomized controlled trials

中医科学杂志（英文）

相似文献

中医科学杂志（英文）

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia:A systematic review and network meta-analysis of randomized controlled trials

中医科学杂志（英文）

相似文献

中医科学杂志（英文）

相关期刊

检索历史清除